Cite
The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema
MLA
Maurer, Marcus, et al. The Icatibant Outcome Survey: 10 Years of Experience with Icatibant for Patients with Hereditary Angioedema. Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......109..e2ed3b0229e256c197830dba4789f86a&authtype=sso&custid=ns315887.
APA
Maurer, M., Aberer, W., Caballero, T., Bouillet, L., Grumach, A. S., Botha, J., Andresen, I., Longhurst, H. J., & IOS Study Group. (2022). The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema.
Chicago
Maurer, Marcus, Werner Aberer, Teresa Caballero, Laurence Bouillet, Anete S Grumach, Jaco Botha, Irmgard Andresen, Hilary J Longhurst, and IOS Study Group. 2022. “The Icatibant Outcome Survey: 10 Years of Experience with Icatibant for Patients with Hereditary Angioedema,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......109..e2ed3b0229e256c197830dba4789f86a&authtype=sso&custid=ns315887.